One of RFK Jr.'s investments: Dragonfly
–– Adelheid "Heidi" Cerwenka
- Mannheim Institute for Innate Immunoscience (MI3)
- Member of Dragonfly Scientific Advisory Board
- Professor, Heidelberg University
- Vice Dean for Research, Medical Faculty
- Head of the Department of Immunobiochemistry
- CBTM and ECAS
Dr. Adelheid (Heidi) Cerwenka, Ph.D., is a world leading scientist in NK cell biology and the innate immune system.
After postdoctoral research at the Trudeau Institute New York and at UCSF, she became group-leader at the Novartis Research Institute before being appointed as group-leader at the DKFZ.
Cerwenka is head of the Department of Immunobiochemistry at the Centrum für Biomedizin und Medizintechnik Mannheim (CBTM) and European Center for Angioscience (ECAS).
She has a Ph.D. from the Institute of Immunology at the University of Vienna, Austria, and the Venia Legendi for Immunology from the Faculty of Medicine, University of Heidelberg.